Comparison of Efficacy and Safety of Two Commercial Artificial Tears Between 0.18% and 0.3% Sodium Hyaluronate for Corneal Epithelial Healing in Pterygium Excision with Conjunctival Autograft Transplantation: A Study Protocol for a Randomized Controlled Trial
DOI: https://doi.org/10.2147/OPTH.S388276
2022-11-30
Clinical Ophthalmology
Abstract:Winai Chaidaroon, Suphitcha Pantarote, Phit Upaphong, Janejit Choovuthayakorn Department of Ophthalmology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand Correspondence: Winai Chaidaroon, Department of Ophthalmology, Faculty of Medicine, Chiang Mai University, 110 Intawaroros Road T.Suthep A.Muang, Chiang Mai, 50200, Thailand, Tel +66-53-935512 ; +66-891415512, Fax +66-53-936121, Email Purpose: To compare the efficacy, safety, and rate of healing on the corneal epithelial defect after pterygium surgery through the application of either 0.18% or 0.3% sodium hyaluronate (SH). Methods: A randomized, double-blind clinical trial was performed on patients who had pterygium surgery. Eighty-six patients were randomized to 2 groups that would receive either 0.18% SH or 0.3% SH. Measurements of area of the corneal epithelial defect using ImageJ freeware were performed. All corneal epithelial defects were measured immediately after the operation (Day 0) and for the next 3 days. Results: The mean and SD of the area of corneal epithelial defect measured on postoperative Day 0, 1, and 2 were 9.13 ± 3.09 mm 2 , 5.61 ± 3.26 mm 2 , and 3.39 ± 2.70 mm 2 for 0.18% SH group, and 8.96 ± 3.17 mm 2 , 4.03 ± 1.99 mm 2 , and 1.55 ± 1.23 mm 2 for 0.3% SH group. There was no statistically significant difference of the initial area of the corneal epithelial defect on Day 0 between 0.18% and 0.3% SH group (p = 0.802). The area of the defects in the 0.3% SH group was significantly smaller than that of the 0.18% SH group on both Day 1 and Day 2 (p = 0.007, p < 0.001), respectively. Similarly, the 0.3% SH group exhibited a statistically significant higher (p < 0.001) rate of healing of the corneal epithelial defect over days 0 and 1 (4.94 ± 2.16 mm2/day) when compared to that of the 0.18% SH group (3.53 ± 1.66 mm2/day). Conclusion: With two commercial artificial tears, the corneal epithelial wound healing after pterygium surgery was faster in the 0.3% SH group than that of the 0.18% SH group. Superiority of 0.3% SH may be supported by the presence of epsilon-aminocaproic acid in this drug preparation. No significant adverse effects were exhibited during the short-term follow-up. Keywords: 0.18% hyaluronic acid, 0.3% hyaluronic acid, hyaluronic acid, corneal epithelial defect, pterygium surgery Although superior conjunctival autograft transplantation for pterygium treatment was a gold standard for pterygium treatment, 1 the corneal epithelial defect always existed after the surgery. Rapid corneal epithelial wound healing could decrease sight-threatening complications, such as infectious keratitis, corneal perforation, or corneal scar, 2,3 and lessen comorbidities reported in these patients, including pain, eye discomfort, and photophobia. 4 Various pharmacological interventions had been described to expedite corneal epithelial healing such as growth factors, 5 corticosteroids, 6 and sodium hyaluronate (SH). 7 SH is a linear, non-sulfated glycosaminoglycan composed of b-1,3-N-acetyl-D-glucosamine and b-1,4-glucuronic acid repeating disaccharide units with viscoelastic rheology. 8–10 With its extraordinary biocompatibility, excellent bioadhesion, and receptor recognition characteristics, SH had been widely used in ophthalmology, including dry eye treatment, drug delivery vehicle, ophthalmic viscoelastic device, and corneal wound repairing. 10 Several studies revealed SH eye drops promoted corneal epithelialization. 11–13 SH eye drops facilitated corneal epithelial healing and the rate of healing associated with the concentration of SH in the animal model study. 13 The purpose of this study is to compare the efficacy between 0.18% and 0.3% SH in terms of corneal epithelial wound healing after pterygium excision with conjunctival autograft transplantation because SH has unique characteristics for corneal wound healing and the higher concentration (0.3% SH) has recently been introduced. To our best knowledge, this is the first study comparing the rate of human corneal epithelial wound healing using 0.18% and 0.3% SH after pterygium surgery. 1. 0.18% SH (Vislube ® preservative-free monodose, Holopack Verpackungstechnik GmbH, Abtsgmünd-Untergröningen, Germany), a monodose unit contains 0.3 mL hypotonic (150 mOsm/L) solution. The molecular weight (MW) of SH is 1.2 × 10 6 Da. It consists of sodium hyaluronate, sodium chloride, potassium chloride, disodium-hydrogen phosphate, sodium citrate, magnesium chloride, calcium chloride, and water for injection. 2. 0.3% SH (Hialid ® Mini 0.3 preservative-free monodose, Santen Pharmaceutical Co., Ltd, Ishikawa, Japan), a -Abstract Truncated-